Gallup found a long-standing divide in how Americans view health care costs. In all, 16% said they are satisfied with the overall cost of U.S. health care, but 57% said they are satisfied with what ...

Score had temporal stability for patients with stable kidney function, but was responsive for only some with worsening disease.

44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years.

In total, the researchers identified 8466 patients who were diagnosed with hiccups during the study period but before a potential cancer diagnosis. The vast majority (89%) were men. The incidence rate ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

(HealthDay News) — Severe valvular heart disease (VHD) is prevalent among patients with cancer and is associated with reduced survival, according to a study presented at the annual congress of the ...

The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...

(HealthDay News) — Zoliflodacin is noninferior to ceftriaxone plus azithromycin for the treatment of uncomplicated urogenital gonorrhea, according to a study published online Dec. 11 in The Lancet.

Biomarkers might improve risk stratification for patients with chronic kidney disease (CKD) at cardiovascular risk.

The FDA has granted traditional approval to Rubraca (rucaparib) for metastatic castration-resistant prostate cancer.

(HealthDay News) — Among persons at high cardiovascular risk, there is low- to moderate-certainty evidence that reducing or modifying saturated fat intake can reduce mortality and major cardiovascular ...

FDA expands Accrufer approval to treat iron deficiency in pediatric patients aged 10 years and older based on phase 3 FORTIS trial outcomes.